RNAZ(RNAZ)
RNAZ
Analyst Coverage
No analyst coverage available for this stock.
PRICE
Prev Close
6.12
Open
6.04
Day Range6.03 – 6.55
6.03
6.55
52W Range5.56 – 20.99
5.56
20.99
4% of range
VOLUME & SIZE
Avg Volume
9.3K
FUNDAMENTALS
P/E Ratio
-1.7x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.34
Market-like
TECHNICAL
RSI (14)
22
Oversold
RNAZ News
About
transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)